4//SEC Filing
CONTE LISA A 4
Accession 0000950170-24-114187
CIK 0001585608other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 9:55 PM ET
Size
8.0 KB
Accession
0000950170-24-114187
Insider Transaction Report
Form 4
CONTE LISA A
DirectorCEO and President
Transactions
- Award
Common Stock
2024-10-08+16,503→ 16,624 total - Award
Stock option (right to buy)
2024-10-08+132,020→ 132,020 totalExercise: $1.29Exp: 2034-10-08→ Common Stock (132,020 underlying)
Footnotes (5)
- [F1]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
- [F2]The option and restricted stock unit grants were approved by the issuer's board of directors on October 8, 2024.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's voting common stock. The restricted stock units vest in three equal annual installments beginning on October 8, 2025. Vested shares will be delivered to the reporting person on the vesting date or dates provided in the grant notice.
- [F4]On May 23, 2024, the issuer effected a 60-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the " Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 60 shares of voting common stock was automatically converted into one share of voting common stock.
- [F5]The options will vest ratably on a monthly basis over 36 months from the grant date, so long as the executive remains employed by the issuer.
Documents
Issuer
Jaguar Health, Inc.
CIK 0001585608
Entity typeother
Related Parties
1- filerCIK 0001008377
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 9:55 PM ET
- Size
- 8.0 KB